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Abstract—In this paper, we revisit the data of the San Antonio
Heart Study, and employ machine learning to predict the future
development of type-2 diabetes. To build the prediction model, we
use the support vector machines and ten features that are well-
known in the literature as strong predictors of future diabetes.
Due to the unbalanced nature of the dataset in terms of the
class labels, we use 10-fold cross-validation to train the model
and a hold-out set to validate it. The results of this study show
a validation accuracy of 84.1% with a recall rate of 81.1%
averaged over 100 iterations. The outcomes of this study can help
in identifying the population that is at high risk of developing
type-2 diabetes in the future.
Index Terms—Disease Prediction, support vector machine, type
2 diabetes.
I. INTRODUCTION
The global incidence of diabetes was estimated at 422 million
in the year 2014, and its prevalence among the adult population
has seen in increase from 4.7% in 1980 to 8.5% in 2014 [1].
In 2015 alone, an estimated 1.6 million deaths worldwide were
directly attributed to diabetes. In addition, a diabetic patient is
at a greater risk of developing cardiovascular disease, visual
impairment and undergo limb amputations, as compared to
a non-diabetic person. Due to the substantial socio-economic
burdens not only to the effected families but the local health-
care system as well, the early detection, intervention and
prevention of diabetes has become a paramount global concern
related to health.
Impaired glucose tolerance (IGT) determines the abnormal
insulin response in the body, and is considered one of the most
important risk factors, both by the World Health Organization
(WHO) [2] and the American Diabetes Association (ADA) [3],
for detecting diabetes in its early stage, known as pre-diabetes.
The IGT can be quantified by the glucose clamp technique,
however, such an experiment is risky and requires highly
qualified personnel, which limits its use in clinical practice
or large epidemiological studies. A less invasive technique
to quantify the IGT involves an oral glucose tolerance test
(OGTT) in which the blood concentrations of glucose and
insulin are assessed, in response to a standardized glucose
dose taken orally before two hours of the measurement, after
an overnight fasting state [4].
Studies have shown that only 50% of the cases that exhibit
the IGT go on to develop diabetes in future [5], [6]. On
the other hand, 40% diabetic subjects do not show any IGT
in the initial screening. Previous studies have shown that
extended the OGTT, that assesses the blood glucose and
insulin intermittently during the 2 h time period can better
predict the future risk of type-2 diabetes [7]. In this paper,
we extract the extended OGTT data from a population-based,
epidemiological study, the San Antonio Heart Study (SAHS)
[8], [9], and use a machine learning model to predict the future
risk of diabetes. We use ten features that include a subject’s
demographic information and glucose characteristics derived
from the OGTT measurements. The features are well-known
as strong predictors of future diabetes in the literature. Here,
we first describe the background and of the SAHS, after which
we illustrate the machine learning technique used in this study.
The results obtained during the training and validation phases
are reported in terms of the accuracy, recall and specificity of
the classifier models. Since the aim is to identify the high-risk
subjects, we optimize the training models so that the recall
(true positive rate) is maximized.
II. METHODOLOGY
A. San Antonio Heart Study
We extracted the dataset from an epidemiological population
study of risk factors related to diabetes and cardiovascular
diseases, known as the San Antonio Heart Study (SAHS) [8],
[9]. The study comprised of 5,158 men and non-pregnant
women of Mexican-American and non-Hispanic white eth-
nicity, aged between 25 and 64 years and residing in San
Antonio, Texas. All the protocols applied in the study were
approved by the University of Texas Health Science Center,
San Antonio institutional review board. Blood samples of all
the participants that went through an overnight fast, were
drawn after orally administering a 75 g dose of glucose. After
an average follow-up period of 7.5 years, the same participants
were subjected to another round of OGTT. The participants
in the SAHS study were enrolled in 2 stages, the first from
January 1979 to December 1982, and the second, from January
1984 to December 1988 [10]. The reassessment during the
follow-up period took place from October 1987 to November
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1990 for the first phase, and October 1991 to October 1996
for the second phase. For this paper, we analyzed a subset of
data from the second phase, with plasma glucose and insulin
levels of 1,496 participants measured at 0, 30, 60 and 120
minutes at baseline. At the follow-up assessment (average
follow-up time of 7.5 years), the participants were classified as
having type-2 diabetes (T2D), cardiovascular disease (CVD)
or normal. For the T2D diagnosis, the WHO criteria, defining
fasting glucose level ≥126mg/dL or 2-hour glucose level
≥200mg/dL was followed [11]. Any participant reportedly
taking anti-diabetic medications was also classified as diabetic.
For the CVD classification, any cardiovascular event such as a
heart attack, stroke or angina reported by the participant, was
considered as an identifier. Table I outlines the distribution of
patient classification used in this study. In order to construct
a binary classifier, we have combined labels, T2D and both (a
total of 171 participants) indicating diabetes.
Healthy DMI CVD Both
1,281 161 44 10
85.63% 10.76% 2.94% 0.67%
TABLE I: The classification of the SAHS data-set with a total
of 1496 participants.
B. Feature Selection
We selected 10 features for our prediction model consisting
of socio-demographic variables such as age and ethnicity,
and physiological factors that were either directly measured
or derived from the OGTT. These features have individually
been used in previous T2DM prediction studies [7], [12]. A
complete list of features used is shown in Table II. Subjects
having any missing feature values or labels were excluded
before the model generation. We used Matlab to develop the
machine learning routines and data processing. The area under
the 2 h glucose curve (AuG0−120) was calculated using the
trapezoidal rule, while the Matsuda index (M) was used as
defined in [13]. The insulin sensitivity, ΔI/ΔG0−120, where
x = 30, 120 was calculated using the measured insulin and
glucose values at time x during the OGTT.
Socio-demographic Physiological
Measured Derived
Age BMI AuG0−120
Ethnicity PG0 Matsuda Index (M)
PG120 ΔI/ΔG0−120
ΔI/ΔG0−30 ×M
ΔI/ΔG0−120 ×M
TABLE II: Features used in this study
C. Machine Learning
In this study, we employed the linear SVM kernel by
utilizing the Matlab’s svmtrain function. The training data
was first scaled to have a unit standard deviation. The mis-
classification cost was configured by setting the value of the
boxconstraint parameter to a high value of 100, which
would cause a stricter partitioning of the data with respect to
the class labels.
To predict the future risk of type-2 diabetes, we defined a
positive class (occurrence of diabetes at the follow-up) and a
negative class (healthy). As illustrated in Table I, the OGTT
data used in this study is heavily unbalanced. With 171 positive
class instances as compared to 1281 that of the negative
class, the size of class labels is unbalanced with the ratio of
positive-to-negative instances of 1:8. To avoid the problem of
overfitting to the majority class during the learning phase of
the technique, we under-sampled the majority class (healthy)
to the size of the minority class (diabetic) by a randomly se-
lecting equal number of samples. During the prediction model
generation, we employed 10-fold cross-validation framework
in which 90% of the training data, consisting of 360 samples
was used for training and the remaining 10% was used to
test the model. To validate the trained models, we used a
holdout data set with the same unbalanced ratio of negative-
to-positive classes in the original data, i.e., 11 samples of the
positive class, and 88 samples of the negative class. We started
our experiments using one feature at a time, and then more
number of features were incrementally added. This exercise
assists in discovering any feature dependencies. In total, we
performed 1,023 classification experiments. Each of these
experiments was trained as a 10-fold cross-validation (CV)
and, to minimize the effect of random selection of samples
from the majority class, 100 iterations were performed for each
experiment. Owing to the small sample size of the holdout
dataset, this strategy ensures the unbiased reporting of the
classifier performance. To maximize reliability of the model to
predict diabetes events, we maximized the recall metric during
the training phase, which is defined as,
Recall =
TP
TP + FN
, (1)
where TP and FN are the true-positives and false-negatives
respectively. During the validation phase, we tracked the
confusion matrices for all the models yielding the maximum
training recall for all the feature combinations.
III. RESULTS
The aim of this paper is to devise a machine learning scheme
that can identify healthy subjects that are at an increased risk
of developing type-2 diabetes. For this, the data used here is
a subset of the SAHS that includes the OGTT data of 1,496
healthy subjects at baseline, out of which 171 were labeled
as diabetic at the follow-up assessment and 1,281 maintained
their healthy status. To determine the performance of our pre-
diction models, we use accuracy, recall and specificity of the
models. During the training, we emphasized on maximizing
the recall of the classifier which in other words, maximizes
the identification rate of high-risk diabetes. Using the strategy
described in the previous section, we show the performance
results that are averaged over 100 iterations.
A. Training
We trained ten prediction models with an increasing number
of features. Each of the SVM classifiers was trained through
a 10-fold cross-validation. The trained model was obtained by
selecting the one that yielded the maximum accuracy averaged
over 100 iterations. As an example, the feature, AuG0−120
provided a mean accuracy of 72% which was greater than the
accuracy given by all the other one feature models. The model
obtained using a combination of two features (AuG0−120 and
PG120) generated 84% accuracy. In the meantime, the recall
increased from 94% to 97% by adding one feature. The max-
imum average accuracy during the training was obtained when
four features (AuG0−120, PG120, age, and ethnicity) were used
(see Table III). The performance did not improve with further
increments in the number of features. This suggests that the
newly added features may not be independent to the existing
ones.
Features Accuracy Specificity Recall
1 0.72 0.50 0.94
2 0.84 0.75 0.97
3 0.86 0.75 1
4 0.89 0.78 1
5 0.86 0.72 1
6 0.86 0.75 1
7 0.89 0.78 0.97
8 0.89 0.81 0.97
9 0.86 0.78 0.91
10 0.81 0.78 0.81
TABLE III: The averaged performance of the trained models
demonstrating maximum recall and their corresponding accu-
racy and specificity.
B. Validation
To validate the trained models, we used a holdout data set
with the same unbalanced ratio of positive-to-negative class.
Due to the small sample of the minority class and in order
to avoid overlapping with the training set, only 11 diabetic
samples were used. Figure 1 shows the box plots for the
validation recall, accuracy and the specificity of the models
that were trained to maximize the recall rate of the classifier.
The same trends observed during the training were also seen
in the validation phase. The combination of the four features
that yielded the best training performance also produced the
highest median recall rate. Adding more number of features
resulted in slight improvement in the median accuracy. A
worsening trend in the performance was observed when the
number of features was more than seven. Figure 1 shows the
validation performance of the models with maximized recall
during the training.
IV. DISCUSSION
Development of the classifiers on an unbalanced dataset poses
a typical machine learning problem that results in he trained
models being biased towards the majority class. In this study,
we balanced the two classes with the aim to get unbiased
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Fig. 1: The validation performance of the models with maxi-
mized training recall. The box plots were obtained after 100
iterations of running the classifier.
models in the training. The classification threshold that con-
trols the probability of a sample belonging to a certain class,
can be varied to maximize the true positive rate (recall) of the
classifier. Validation on the holdout data, on the other hand
provides an independent assessment of the classifier.
V. CONCLUSIONS
Diabetes prediction models identify the high-risk population
so that a timely population-based intervention could prevent
future complications. In this paper, we used the linear support
vector machines to construct a prediction model of future
development of type-2 diabetes.
The outcomes of the study show that high values of glucose
observed at the 2 h mark during the OGTT may strongly
indicate the potential risk of future development of type-2
diabetes. In a possible extension of this study, the prediction
models may be applied on other similar datasets that include
the OGTT measurements.
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